Abstract
Objective
The excessive proliferation of fibroblast-like synoviocytes (FLSs) is a key inducement for the occurrence and development of rheumatoid arthritis (RA). Hypoxia inducible factor-α (HIF-α) accumulation is involved in the regulation of cell biological functions in the hypoxic microenvironment of synovium. This study aimed to investigate the roles of HIF-α and its level regulator prolyl hydroxylases (PHDs) in FLSs proliferation and to explore the regulatory effect of geniposide (GE).
Materials and methods
Adjuvant arthritis rats and RA-FLSs cell line MH7A were taken as the research objects. MH7A cells were incubated in a hypoxic chamber with 2% O2 for hypoxia treatment. CCK-8, FACS, EdU and Western blot assays were performed to evaluate MH7A cells proliferation. Iron assay was conducted to determine intracellular Fe2+ level.
Results
MH7A cells proliferation was significantly enhanced under hypoxia, accompanied by an increase of HIF-1α level. Decreased HIF-1α level by PX-478 inhibited MH7A cells proliferation. Furthermore, PHD2 was highly expressed in vivo and in vitro, and played a key role in modulation of HIF-1α protein level, which was confirmed by PHD2 inhibitor IOX4 and proteasome inhibitor MG132. GE treatment alleviated synovial hyperplasia in AA rats and inhibited MH7A cells proliferation with a reduction in HIF-1α level. Fe2+ acts as an enzymatic cofactor to control PHD2 activity. Iron assay showed that GE reversed the decline of Fe2+ level in MH7A cells under hypoxia.
Conclusion
GE attenuates abnormal proliferation of RA-FLSs via inhibiting HIF-1α accumulation through enhancement of PHD2 activity.
Similar content being viewed by others
References
Firestein GS, McInnes IB. Immunopathogenesis of rheumatoid arthritis. Immunity. 2017;46:183–96.
Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110–4.
Mankia K, Emery P. Is localized autoimmunity the trigger for rheumatoid arthritis? Unravelling new targets for prevention. Discov Med. 2015;20:129–35.
Ganesan R, Rasool M. Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: current status and future directions. Int Rev Immunol. 2017;36:20–30.
Sun W, Ma J, Zhao H, et al. Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis. Arthritis Res Ther. 2020;22:61.
Ivan M, Kaelin WG Jr. The EGLN-HIF O2-sensing system: multiple inputs and feedbacks. Mol Cell. 2017;66:772–9.
Deng W, Feng X, Li X, et al. Hypoxia-inducible factor 1 in autoimmune diseases. Cell Immunol. 2016;303:7–15.
Watts ER, Walmsley SR. Inflammation and hypoxia: HIF and PHD isoform selectivity. Trends Mol Med. 2019;25:33–46.
Hu F, Liu H, Xu L, et al. Hypoxia-inducible factor-1α perpetuates synovial fibroblast interactions with T cells and B cells in rheumatoid arthritis. Eur J Immunol. 2016;46:742–51.
Ryu JH, Chae CS, Kwak JS, et al. Hypoxia-inducible factor-2α is an essential catabolic regulator of inflammatory rheumatoid arthritis. PLoS Biol. 2014;12: e1001881.
Hu Y, Liu X, Xia Q, et al. Comparative anti-arthritic investigation of iridoid glycosides and crocetin derivatives from gardenia jasminoides ellis in freund’s complete adjuvant-induced arthritis in rats. Phytomedicine. 2019;53:223–33.
Shan M, Yu S, Yan H, et al. A review on the phytochemistry, pharmacology, pharmacokinetics and toxicology of geniposide, a natural product. Molecules. 2017;22:1689.
Li N, Li L, Wu H, Zhou H. Antioxidative property and molecular mechanisms underlying geniposide-mediated therapeutic effects in diabetes mellitus and cardiovascular disease. Oxid Med Cell Longev. 2019;2019:7480512.
Li F, Dai M, Wu H, et al. Immunosuppressive effect of geniposide on mitogen-activated protein kinase signalling pathway and their cross-talk in fibroblast-like synoviocytes of adjuvant arthritis rats. Molecules. 2018;23:91.
Wang RH, Dai XJ, Wu H, et al. Anti-inflammatory effect of geniposide on regulating the functions of rheumatoid arthritis synovial fibroblasts via inhibiting sphingosine-1-phosphate receptors1/3 coupling gαi/gαs conversion. Front Pharm. 2020;11: 584176.
Wang Y, Wu H, Deng R, et al. Geniposide downregulates the VEGF/SphK1/S1P pathway and alleviates angiogenesis in rheumatoid arthritis in vivo and in vitro. Phytother Res. 2021;35:4347–62.
Sun M, Deng R, Wang Y, et al. Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: a novel target of geniposide to inhibit angiogenesis. Life Sci. 2020;256: 117988.
Chen JY, Wu H, Li H, et al. Anti-inflammatory effects and pharmacokinetics study of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2015;24:102–9.
Dai MM, Wu H, Li H, et al. Effects and mechanisms of geniposide on rats with adjuvant arthritis. Int Immunopharmacol. 2014;20:46–53.
Castelli S, Ciccarone F, Tavian D, et al. ROS-dependent HIF1α activation under forced lipid catabolism entails glycolysis and mitophagy as mediators of higher proliferation rate in cervical cancer cells. J Exp Clin Cancer Res. 2021;40:94.
Li G, Yang T, Chen Y, et al. USP5 sustains the proliferation of glioblastoma through stabilization of CyclinD1. Front Pharm. 2021;12: 720307.
Kang MS, Ryu E, Lee SW, et al. Regulation of PCNA cycling on replicating DNA by RFC and RFC-like complexes. Nat Commun. 2019;10:2420.
Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9:24–33.
Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233:233–55.
Liu N, Feng X, Wang W, et al. Paeonol protects against TNF-α-induced proliferation and cytokine release of rheumatoid arthritis fibroblast-like synoviocytes by upregulating FOXO3 through inhibition of miR-155 expression. Inflamm Res. 2017;66:603–10.
He SD, Huang SG, Zhu HJ, et al. Oridonin suppresses autophagy and survival in rheumatoid arthritis fibroblast-like synoviocytes. Pharm Biol. 2020;58:146–51.
Chen D, Wu YX, Qiu YB, et al. Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK/HO-1 axis. Phytomedicine. 2020;67: 153138.
Bahrami A, Atkin SL, Majeed M, et al. Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. Pharm Res. 2018;137:159–69.
Chen J, Cheng W, Li J, et al. Notch-1 and notch-3 mediate hypoxia-induced activation of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheumatol. 2021;73:1810–9.
Wohlrab C, Kuiper C, Vissers MC, et al. Ascorbate modulates the hypoxic pathway by increasing intracellular activity of the HIF hydroxylases in renal cell carcinoma cells. Hypoxia (Auckl). 2019;7:17–31.
Nguyen TL, Durán RV. Prolyl hydroxylase domain enzymes and their role in cell signaling and cancer metabolism. Int J Biochem Cell Biol. 2016;80:71–80.
Wollenick K, Hu J, Kristiansen G, et al. Synthetic transactivation screening reveals ETV4 as broad coactivator of hypoxia-inducible factor signaling. Nucleic Acids Res. 2012;40:1928–43.
Bagnall J, Leedale J, Taylor SE, et al. Tight control of hypoxia-inducible factor-α transient dynamics is essential for cell survival in hypoxia. J Biol Chem. 2014;289:5549–64.
Henze AT, Riedel J, Diem T, et al. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res. 2010;70:357–66.
Lee SY, Kim HJ, Oh SC, et al. Genipin inhibits the invasion and migration of colon cancer cells by the suppression of HIF-1α accumulation and VEGF expression. Food Chem Toxicol. 2018;116:70–6.
Tu Y, Li L, Zhu L, et al. Geniposide attenuates hyperglycemia-induced oxidative stress and inflammation by activating the Nrf2 signaling pathway in experimental diabetic retinopathy. Oxid Med Cell Longev. 2021;2021:9247947.
Park YH, Bae HC, Kim J, et al. Zinc oxide nanoparticles induce HIF-1α protein stabilization through increased reactive oxygen species generation from electron transfer chain complex III of mitochondria. J Dermatol Sci. 2018;91:104–7.
Acknowledgements
All the animal experiments were approved by the experimental animal ethics committee of Anhui University of Chinese Medicine (No. AHUCM-rats-2021049).
Funding
This work was supported by the National Natural Science Foundation of China (No 81473400; No 81874360).
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. Experiment implementation and data analysis were performed by PG, MS, Professor HW, JK, XD and FC. The manuscript was written by PG.
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gan, P., Sun, M., Wu, H. et al. A novel mechanism for inhibiting proliferation of rheumatoid arthritis fibroblast-like synoviocytes: geniposide suppresses HIF-1α accumulation in the hypoxic microenvironment of synovium. Inflamm. Res. 71, 1375–1388 (2022). https://doi.org/10.1007/s00011-022-01636-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-022-01636-5